+ All Categories
Home > Documents > Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal...

Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal...

Date post: 24-Aug-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
33
Lessons Learnt from NMRC and non-NMRC Funded Research: Meningococcal Disease, Dengue and Zika Annelies Wilder-Smith MD PhD Professor of Infectious Diseases Research
Transcript
Page 1: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Lessons Learnt from NMRC and non-NMRC Funded Research:

Meningococcal Disease, Dengue and Zika

Annelies Wilder-Smith MD PhD

Professor of Infectious Diseases Research

Page 2: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Hajj pilgrimage

BIO/ACWY/0007g/12

Page 3: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

International W-135 outbreak in 2000 and 2001Netherlands,

2001 (3)2 Norway

Sweden Finland

Denmark

France, 2001 (14)2

Spain, 2001 (16)2

US

Morocco

Singapore,

2000–2001

(12)3

Indonesia

Saudi Arabia, 2000 (n=93)1

Oman

Kuwait

Germany, 2001 (6)2

UK, 2001 (59)2

1Lingappa JR, et al. Emerg Infect Dis. 2003;9:665–71; 2Hahné S, et al. Lancet 2002;360:2089–90; 3Wilder-Smith A, et al. Clin Infect Dis

2003;36:679–83

BIO/ACWY/0007g/12Date of preparation: June 2012

Page 4: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Research ideas

•Where do ideas come from?

Page 5: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Risk factors and at-risk groups

Immature immune

system1

Impaired immune

system2,3

Nasopharyngeal

irritation3 Social factors3,4

Infants Complement

deficiency

Humoral immune

deficiency states

Asplenia

HIV/AIDS

Smoking

Respiratory tract

infection

Close contact with

a case

Crowding

Most cases of meningococcal disease occur in previously healthy persons without identified risk factors. Overcrowding is the MAIN risk risk

1Rosenstein NE et al. N Engl J Med 2001;344:1378–88; 2Figueroa JE et al. Clin Microbiol Rev 1991;4:359–95;3Bilukha OO et al. MMWR Recomm Rep 2005;54:1–21; 4Imrey PB et al. J Clin Microbiol 1995;33:3133–7 (copyright-free images)

BIO/ACWY/0007g/12

Page 6: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Carriage rates of W-135 in Singaporean pilgrims and transmission to household

contacts in 2001

Wilder-Smith A et al. BMJ 2002;325:365–6

Pre-HajjpilgrimsN=204

Post-HajjpilgrimsN=171

Household contactsN=233

W-135 carriage 0 15% 3%

BIO/ACWY/0007g/12Date of preparation: June 2012

Page 7: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

1 2 3 4 5 6 7 8 9

Fig 1. PFGE gel.

Lane 1, W135 from a pilgrim: 2, W135 from the pilgrim’s contact: 3, W135

from a clinical case in 2001: 4, a non-groupable pilgrim’s isolate: 5 , W135

from a pilgrim: 6, an autoagglutinator from a pilgrim: 7, Lambda ladder in

kb: 8, W135 from a pilgrim: 9, W135 from a clinical case in 2000.

48

97

145

194

242

Page 8: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Case study: international Neisseria meningitidis W-135 outbreak 2000

W-135 carriage in returning pilgrims was 15%1

The rate of transmission to household contacts was 8%1,2

Invasive W-135 disease in contacts occurred in 1 case per 70 acquisitions1

1Wilder-Smith A et al. Clin Infect Dis 2003;36:679–83; 2Wilder-Smith et al. Emerg Infect Dis 2003;9:123–6 (Copyright free image)

BIO/ACWY/0007g/12

Page 9: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

The Research Spiral

Page 10: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Early versus late transmission to household contacts

Wilder-Smith A, Barkham TMS, Ravindran S, Earnest A, Paton NI.

Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts. Emerg Infect Dis 2003

Page 11: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Conclusions

• Returning pilgrims carrying the W135 clone transmitted it to 8 % of their household contacts

• Acquisition only occurred in the first month of contact with the returning pilgrim carriers, and none of the contacts with initially negative results acquired the strain after months of exposure.

• The absence of late transmission is an important new finding

Wilder-Smith A, Barkham TMS, Ravindran S, Earnest A, Paton NI.

Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts. Emerg Infect Dis 2003

Page 12: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Hahne, et al. Lancet 2002 February 16, 359.

Cases of invasive W135 disease, in England and Wales

by onset

Week of onset

2000 2001

Hajj 2001

Hajj 2000

Pilgrim

Contact of pilgrim

No Known contact with pilgrims

14

12

10

8

6

4

2

01 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 1 3 5 7 9 11 13 15 17 19

Page 13: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Case study: international Neisseria meningitidis W-135 outbreak 2000

Of 90 confirmed cases of W-135 disease throughout Europe

• Only 12 (13%) cases were pilgrims

• 31 (34%) infected through contact within same household

• 21 (23%) infected outside household

• No pilgrim contact identified for 26 cases (29%)

The infection spread rapidly

• 45 (50%) cases occurred during the first 4 weeks after the first return of pilgrims

Distribution of 90 cases

42

24

1 8

23 2

Not only may travelers themselves be at risk of contracting IMD,but their close contacts (family and friends) may be at risk too

Aguilera J-F, Perrocheau A, Meffre C, Hahné S. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000.

Emerg Infect Dis [serial online] 2002 Aug [cited 2012 June 7]. Available from: http://wwwnc.cdc.gov/eid/article/8/8/01-0422.htm

BIO/ACWY/0007g/12Date of preparation: June 2012

Page 14: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Spread of W-135

Amplified in Saudi Arabia during 2000 Hajj pilgrimage1,2

Spread to Africa2,3

Caused a major outbreak in Burkina Faso in 2002 with >14000 cases4

W-135

1Cohn A and Jackson M. Travelers’ Health: CDC Travelers’ Health: Yellow Book 2012. http://wwwn.cdc.gov/travel/yellowbookCh4-Menin.aspx; 2Lingappa JR, et al. Emerg Infect Dis. 2003;9:665–71; 3von Gottberg A, et al. Clin Infect Dis 2008;46:377–86; 4Caugant et al. Vaccine 2007;25:A8–A11

BIO/ACWY/0007g/12Date of preparation: June 2012

Page 15: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

The Research Spiral

Page 16: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Same study for 2002

Pre Hajj

N=193

Post Hajj

N=153 (79%)

Carriage 2% 1.3%

W135 Carriage 0 1.3%

Wilder-Smith A, Barkham TMS, Chew SK, Paton NI. Absence of Neisseria meningitidis W-135 electrophoretic type 37 during the Hajj, 2002.

Emerg Infect Dis 2003

After the introduction of compulsory quadrivalent meningococcalvaccination for pilgrims attending the Hajj in 2001, no pilgrims

developed W-135 disease1,2

Page 17: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Sri Lanka

Page 18: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

DengueTools Consortium – 14 partners worldwide, funded by the European

Commission with 5.6 million Euro

Page 19: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Prevention

WP4Novel strategies to prevent Dengue in school children -

Impregnated school uniforms: a randomized control trial

WP5Repellent efficacy of

impregnated uniforms

Surveillance

WP1Integrated surveillance and

early warning systems

WP2Novel diagnostic assays

for resource limited settings

WP3Novel tools for vector

Surveillance

Risk of introduction to uninfected regions

WP7Surveillance and control of Aedes albopictus in Europe

WP6Sentinel surveillance

of imported dengue to Europe: trends and virus evolution

WP8Climate change, global mobility

and population dynamics: predictive models

Cross-cutting

WP9Research conduct data

management and modelling

WP11Economic evaluation

and evidence-informed policy making

WP10Geo-spatial modelling

and risk maps

WP12 Management and Dissemination

Page 20: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Sri Lanka

Page 21: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Our study, which is part of the EU/FP7-funded DengueTools Consortium, aims at

finding an alternative solution for dengue prevention and control in the most

vulnerable school-age children

OUR OBJECTIVE: A BETTER TOOL FOR

DENGUE PREVENTION IN CHILDREN

Anatapreecha and et, al.

Epidemiol. Infection

(2005)

Sri Lanka

Page 22: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Labotoratory based efficacy

– WHOPES cone tests

3 min exposure 1 hour knockdown (KD) 24 hour mortality 100, 70, 50, 20, 5, 0 washes

– Repellency arm-in-Cage test

30 Stegomyia aegypti (susceptible and resistant) 1.5 min exposure to arm covered by

treated material Landing and biting recorded

Sri Lanka

Page 23: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

WHOPES cone test

% m

osq

uito

es

Factory dipping Insect Shield yielded higher KD and mortality

Craghoppers microencapsulation technique significantly lower at the 1 hour KD (p<0.0005)

Sri Lanka

Page 24: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Repellency

• Treated clothing gave 100% protection; untreated clothing gave~96% protection

• Treated partial coverage gave ~47% protection after 1 wash; untreated partial

coverage gave 20% protection

0

20

40

60

80

100

FC (bare) FC (control) Control

% P

rote

cti

on

Full Coverage Biting Washed Material

-20

0

20

40

60

80

100

PC (bare) PC (control) Control

% P

rote

cti

on

Partial Coverage Biting Washed Material

0

1

5

10

Sri Lanka

Page 25: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Study design

• Cluster Randomized placebo-controlled school based

trial

• 10 schools

• 2000 children aged 5-13

• Cross-over design

Innovative tools and strategies for surveillance and control of dengue

29

Work

package

number

WP 4 Starting date or starting event 1

Work

package

title

Novel strategies to prevent dengue in school children

Activity

type

RTD

Participan

t number 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Participan

t short

name

Um

U

SR

L

TD

X

U

M

OXT

C

MA

H

LSHT

M

STP

H

I

P

UKL

-HD

DKN

S

US

P

ISCII

I

EI

D

Person-

months

180 2

Overall objective(s)

To determine the impact of impregnated (pre-fabricated) school uniforms on dengue incidence in school aged children

with a randomized controlled trial using a cross-over design

Specific objectives

1. To measure the protective herd effect (halo effect) on children without impregnated clothes

2. To evaluate the safety and acceptability of impregnated school uniforms in a community setting

3. To investigate the effect of impregnated school uniforms on vector indices in and around schools

4. To measure the reduction in absenteeism from school as a result of the intervention

Description of work

Background: Children carry the main burden of morbidity and mortality for dengue. As Aedes mosquitoes are active

mainly during the day, children are at high risk during daytime activities. As children spend a considerable amount of

their day at school, schools should be a key target for control. School uniforms are a cultural norm in most developing

countries, worn throughout the day on an almost daily basis. Pyrethroid-based insecticides such as permethrin has

been successfully used as insect repellent, with an excellent safety record. Commercially available engineered fabrics

which bind a proprietary permethrin formula tightly to fabric fibres resulting in effective, odourless insect protection

are available that lasts for more than 70 washings. Insecticide-treated clothes have been implemented in both military

and recreational markets, but never been tested for school children. We propose to study the impact on reduction of

dengue incidence in school-aged children.

Approach: We will conduct a randomized controlled trial using a cross-over design over 2 years. Sample size is at

least 1800 students. Study site: in more than 6 schools north-east of Bangkok, Thailand, where Partner #6 has already

established good community contact. We will use pre-fabricated engineered impregnated school uniforms to ensure

consistent high quality of impregnation. However, a qualitative questionared interview related to the home dipping

versus pre-frabricated impregnated school uniforms, taking into account of the gender issue, will be conducted. In our

study, the same coloured uniform skirts or toursers and sport or scout pants will be used in both treatment and control

schools to avoid bias in differential attracting potentials of the uniform colour to mosquitoes. Colour of the school

uniforms could become a confounder, e.g., darker colour may attract more mosquitoes. (Where should we address the

safety issue?)

schools first 6-month

transmission season

washout/crossover period

during non-transmission

season

second 6-month

transmission season

1 intervention Crossover control

2 control Crossover intervention

3 intervention Crossover control

4 control Crossover intervention

5 intervention Crossover control

Sri Lanka

Page 26: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Hua Sam Rong

Ao Chang Lai

Nong Mai Kaen

Sai Thong Uppatham

Wang Ka Ja

Taladbangbo

Tung-Sadao

Nong Prue Prachasan

Wang Yen

Krok Kaeo Wong Phrachan

3 km.

A double-blind randomized trial in 10 schools with 1,825 enrolled students in Chachoengsao Province, eastern Thailand.

OUR STUDY AREA

Sri Lanka

Page 27: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Sri Lanka

Page 28: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

SCHOOL MEETINGS TO INFORM TEACHERS, PARENTS

AND STUDENTS

Sri Lanka

Page 29: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Mortality and KD

0

10

20

30

40

50

60

70

80

90

100

0 Washes 1 Wash 5 Washes 10 Washes 15 Washes 20 Washes 25 Washes 30 Washes

Knockdown

Mortality

W0 W1 W5 W10 W15 W20 W25 W30

Knockdown

100% 99% 92% 75% 54.5% 39% 20% 11.5%

Mortality 93.5% 91.5% 61% 59% 45% 34% 19% 15.5%Sri Lanka

Page 30: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf
Page 31: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Outcome from these 2 research areas?

• Publications:

• From W-135 meningococcal disease: 15

• From DengueTools: 53

• Lessons learnt:

• Ideas create new ideas. Timing is of essence in emerging infectious diseases and outbreak situations

• Consortium approach is not additive, but synergistic

Page 32: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

Uma nova epidemia

Rio de Janeiro

Page 33: Lessons Learnt from NMRC and non-NMRC Funded ......1. To measure the protecti ve herd ef f ect (hal o ef f ect) on chi l dren wi thout i mpregnated cl othes 2. To eval uate the saf

1 MERG: unravelling Congenital Zika Syndrome 2 NEURO-Zika: neurological

manifestations

3 Non-Vector Transmission of ZIKV

4 NEURO-Zika: pathogenesis

8 Disease Burden and Risk Assessment

10 WEAR : Wearable Aedes Repellant Technologies

12 Dissemination and Communication 11 PLAN: Preparedness Latin-

American Network13 Consortium

Coordination

6

5 Platform for Diagnostics Innovation and Evaluation

7

9 Mathematical modelling to inform public health policies

INVADE: Investigating Vaccines in Antibody Dependent Enhancement

Viral Fitness: current versus historic ZIKV strains


Recommended